PRMT1 and amyotrophic lateral sclerosis: Interestingly, as previously reported, we showed that inhibition of Prmt1 after the transfection of Fus constructs results in increased recruitment of wild-type and ALS-Fus mutants to cytoplasmic aggregates (28–29).